But better productivity and a bigger bottom-line isn’t all there is: stock prices get a big boost too. The study also found that the stock value of firms in medical-friendly states jumped by 4.56%, while an “equal-weighted portfolio” of similar stocks in states that don’t have cannabis laws saw a drop of around 2% each year. What’s more, stock returns saw a 4.44% increase annually for companies with legal cannabis laws.